Open AccessStage IV Non-small Cell Lung Adenocarcinoma in Complete Response for 5 Years Post-first-line Nivolumab Immunotherapy: Are We Talking about a Cure?
Author(s) -
Aref Chelal,
Ashraf ALakkad,
Ashok Uttamchandani,
Sonia Otsmane
Publication year - 2022
Publication title -
international journal of medical and pharmaceutical case reports
Language(s) - English
Resource type - Journals
ISSN - 2394-109X
DOI - 10.9734/ijmpcr/2022/v15i430170
Subject(s) - medicine , adenocarcinoma , brain metastasis , lung cancer , lung , nivolumab , radiology , metastasis , surgery , cancer , immunotherapy